产品名称 | 产品编号 | 浓度/详细参数 | CAS号 | 规格/计量单位 | 价格 | 货期 | 品牌 |
---|---|---|---|---|---|---|---|
BTX161 | B646408-5mg | ≥98% | 2052301-24-1 | 5mg | ¥ 3800.9 | 期货,请咨询 | 阿拉丁 |
BTX161 | B646408-25mg | ≥98% | 2052301-24-1 | 25mg | ¥ 11500.9 | 期货,请咨询 | 阿拉丁 |
BTX161 | B646408-10mg | ≥98% | 2052301-24-1 | 10mg | ¥ 6000.9 | 期货,请咨询 | 阿拉丁 |
BV02 | B646381-5mg | ≥99% | 292870-53-2 | 5mg | ¥ 1300.9 | 期货,请咨询 | 阿拉丁 |
BV02 | B646381-50mg | ≥99% | 292870-53-2 | 50mg | ¥ 6150.9 | 期货,请咨询 | 阿拉丁 |
BV02 | B646381-25mg | ≥99% | 292870-53-2 | 25mg | ¥ 3895.9 | 期货,请咨询 | 阿拉丁 |
BV02 | B646381-10mg | ≥99% | 292870-53-2 | 10mg | ¥ 2050.9 | 期货,请咨询 | 阿拉丁 |
BV02 | B646381-100mg | ≥99% | 292870-53-2 | 100mg | ¥ 9720.9 | 期货,请咨询 | 阿拉丁 |
BI-4924 | B646378-5mg | ≥99% | 2244452-09-1 | 5mg | ¥ 6500.9 | 期货,请咨询 | 阿拉丁 |
BI-4924 | B646378-50mg | ≥99% | 2244452-09-1 | 50mg | ¥ 26500.9 | 期货,请咨询 | 阿拉丁 |
BI-4924 | B646378-25mg | ≥99% | 2244452-09-1 | 25mg | ¥ 16500.9 | 期货,请咨询 | 阿拉丁 |
BI-4924 | B646378-10mg | ≥99% | 2244452-09-1 | 10mg | ¥ 9500.9 | 期货,请咨询 | 阿拉丁 |
Bufarenogin | B646372-5mg | 17008-65-0 | 5mg | ¥ 1700.9 | 期货,请咨询 | 阿拉丁 | |
Bufarenogin | B646372-1mg | 17008-65-0 | 1mg | ¥ 680.9 | 期货,请咨询 | 阿拉丁 | |
Bufarenogin | B646372-10mg | 17008-65-0 | 10mg | ¥ 2700.9 | 期货,请咨询 | 阿拉丁 | |
BRD5529 | B646355-5mg | ≥98% | 1358488-78-4 | 5mg | ¥ 1100.9 | 期货,请咨询 | 阿拉丁 |
BRD5529 | B646355-50mg | ≥98% | 1358488-78-4 | 50mg | ¥ 5600.9 | 期货,请咨询 | 阿拉丁 |
BRD5529 | B646355-25mg | ≥98% | 1358488-78-4 | 25mg | ¥ 3600.9 | 期货,请咨询 | 阿拉丁 |
BRD5529 | B646355-10mg | ≥98% | 1358488-78-4 | 10mg | ¥ 1800.9 | 期货,请咨询 | 阿拉丁 |
BRD5529 | B646355-100mg | ≥98% | 1358488-78-4 | 100mg | ¥ 8500.9 | 期货,请咨询 | 阿拉丁 |
Batatasin III | B646318-5mg | ≥99% | 56684-87-8 | 5mg | ¥ 9800.9 | 期货,请咨询 | 阿拉丁 |
Batatasin III | B646318-10mg | ≥99% | 56684-87-8 | 10mg | ¥ 15600.9 | 期货,请咨询 | 阿拉丁 |
BAN ORL 24 | B646299-50mg | ≥98% | 1401463-54-4 | 50mg | ¥ 4185.9 | 期货,请咨询 | 阿拉丁 |
BAN ORL 24 | B646299-10mg | ≥98% | 1401463-54-4 | 10mg | ¥ 1116.9 | 期货,请咨询 | 阿拉丁 |